Few & Far Between: How Biotech Gets Built cover art

Few & Far Between: How Biotech Gets Built

Few & Far Between: How Biotech Gets Built

Written by: Chris O'Brien
Listen for free

About this listen

Welcome to Few & Far Between! Chris O'Brien, CEO of Biorasi, is your host for fascinating conversations - from clinical research and policymakers to biotech innovators and industry leaders.© 2023 Biological Sciences Hygiene & Healthy Living Physical Illness & Disease Psychology Psychology & Mental Health Science
Episodes
  • Video Episode 67: Aoife Brennan, President and CEO of Climb Bio
    Jan 7 2026

    Let's kick off 2026 with the first Biorasi podcast episode of the year!

    How do you get "Biotech Vision" to see the complete picture of your place in the industry?

    Find out in the latest episode of the Few & Far Between podcast - How Biotech Gets Built. Host Chris O'Brien welcomes guest Aoife Brennan, President and CEO of Climb Bio. We'll be discussing how to leverage science and strategy, the differences between CEOs and CMOs, and how hiring an "operational penknife" is critical to new organizations.

    Watch it today!

    Show More Show Less
    1 hr and 12 mins
  • Episode 66: Mark Abelson, Founder of Ora Clinical
    Dec 16 2025

    Are clinical trial protocols a true art form?

    Find out in a new episode of the Biorasi Few & Far Between podcast. Host Chris O'Brien welcomes guest Mark Ableson, founder of Ora Clinical and CRO pioneer.

    We'll be discussing exploratory endpoints, what to learn from failed trails, and essential factors in choosing a clinical site location.

    Listen today!

    Show More Show Less
    43 mins
  • Video Episode 65 - Amit Etkin, Founder and CEO of Alto Neuroscience
    Nov 24 2025

    With biotech, is it the destination, the journey, or both?

    Find out in a new episode of the Biorasi Few & Far Between podcast. Host Chris O'Brien welcomes guest Amit Etkin, Founder and CEO of Alto Neuroscience and Professor of Psychiatry at Stanford University School of Medicine. We’ll be discussing placebos in psychiatry, using biomarkers for patient outcomes, and what you can and can’t do in academia and biotech.

    Watch it today!

    Show More Show Less
    1 hr and 7 mins
No reviews yet